Trials of adult stem cells are more common than embryonic research

08/2/2010 | Los Angeles Times (tiered subscription model)

The use of adult stem cells in clinical trials for the treatment of multiple sclerosis, blood diseases and other conditions has become more prevalent than embryonic stem cell studies because of the ethical debate surrounding embryo-derived cells. Although embryonic stem cells hold promise for the development of replacement tissues, such cells are more likely to be used in the near term as laboratory tools for identifying therapeutic compounds and studying the origins of diseases.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX